PharMerica (PMC) Posts Mixed Q4 Results

PharMerica (NYSE: PMC) reported Q4 EPS of $0.27, $0.06 better than the analyst estimate of $0.21. Revenue for the quarter came in at $495.6 million versus the consensus estimate of $504.17 million.

For earnings history and earnings-related data on PharMerica (PMC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c